130 related articles for article (PubMed ID: 9544640)
1. Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels.
Karcioglu ZA; El-Yazigi A; Jabak MH; Choudhury AH; Ahmed WS
Ophthalmology; 1998 Apr; 105(4):658-61. PubMed ID: 9544640
[TBL] [Abstract][Full Text] [Related]
2. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
3. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
4. Ocular levels of azithromycin.
Tabbara KF; al-Kharashi SA; al-Mansouri SM; al-Omar OM; Cooper H; el-Asrar AM; Foulds G
Arch Ophthalmol; 1998 Dec; 116(12):1625-8. PubMed ID: 9869792
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
[TBL] [Abstract][Full Text] [Related]
6. Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits.
Amar T; Caillaud T; Elena PP
Curr Eye Res; 2008 Feb; 33(2):149-58. PubMed ID: 18293185
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
[TBL] [Abstract][Full Text] [Related]
8. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
[TBL] [Abstract][Full Text] [Related]
9. Outcome of azithromycin treatment of active trachoma in Omani school children.
Khandekarf R; Mohammed AJ
East Mediterr Health J; 2003; 9(5-6):1026-33. PubMed ID: 16450533
[TBL] [Abstract][Full Text] [Related]
10. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
[TBL] [Abstract][Full Text] [Related]
11. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
Wolle MA; Muñoz BE; Mkocha H; West SK
Ophthalmology; 2009 Feb; 116(2):243-7. PubMed ID: 19091415
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of azithromycinin rabbit lacrimal glands and conjunctiv a.
Karcioglu ZA; Ahmed WS; Raines D; El-Yazigi A
Ophthalmic Res; 1999; 31(1):47-52. PubMed ID: 9831822
[TBL] [Abstract][Full Text] [Related]
14. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago.
Swanston WH; Prabhakar P; Barrow L; Mahabir BS; Furlonge C
West Indian Med J; 2001 Sep; 50(3):198-202. PubMed ID: 11769023
[TBL] [Abstract][Full Text] [Related]
15. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
17. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?
Bird M; Dawson CR; Schachter JS; Miao Y; Shama A; Osman A; Bassem A; Lietman TM
J Infect Dis; 2003 May; 187(10):1669-73. PubMed ID: 12721948
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
Torkildsen G; O'Brien TP
Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitis.
Garnock-Jones KP
Drugs; 2012 Feb; 72(3):361-73. PubMed ID: 22316352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
